Detalhe da pesquisa
1.
VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease.
Blood
; 121(12): 2336-9, 2013 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23349392
2.
Storage and secretion of naturally occurring von Willebrand factor A domain variants.
Br J Haematol
; 167(4): 529-40, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25103891
3.
Transcriptional and functional profiling identifies inflammation and endothelial-to-mesenchymal transition as potential drivers for phenotypic heterogeneity within a cohort of endothelial colony forming cells.
J Thromb Haemost
; 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38574861
4.
Impact of allele-selective silencing of von Willebrand factor in mice based on a single nucleotide allelic difference in von Willebrand factor.
Thromb Res
; 236: 201-208, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461614
5.
Automated segmentation and quantitative analysis of organelle morphology, localization and content using CellProfiler.
PLoS One
; 18(6): e0278009, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37315066
6.
Small interfering RNA-mediated allele-selective silencing of von Willebrand factor in vitro and in vivo.
Blood Adv
; 7(20): 6108-6119, 2023 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37467023
7.
Intracellular storage and regulated secretion of von Willebrand factor in quantitative von Willebrand disease.
J Biol Chem
; 286(27): 24180-8, 2011 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-21596755
8.
Biogenesis of Weibel-Palade bodies in von Willebrand's disease variants with impaired von Willebrand factor intrachain or interchain disulfide bond formation.
Haematologica
; 97(6): 859-66, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22207689
9.
Ex vivo Improvement of a von Willebrand Disease Type 2A Phenotype Using an Allele-Specific Small-Interfering RNA.
Thromb Haemost
; 120(11): 1569-1579, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32803740
10.
Characterization of large in-frame von Willebrand factor deletions highlights differing pathogenic mechanisms.
Blood Adv
; 4(13): 2979-2990, 2020 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32609846
11.
The R2-haplotype associated Asp2194Gly mutation in the light chain of human factor V results in lower expression levels of FV, but has no influence on the glycosylation of Asn2181.
Thromb Haemost
; 89(3): 429-37, 2003 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-12624624
12.
The R306G and R506Q mutations in coagulation Factor V reveals additional cleavage sites for Activated Protein C in the R313-R321 region and at R505.
Thromb Res
; 125(5): 444-50, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20051284
13.
Factor Va is inactivated by activated protein C in the absence of cleavage sites at Arg-306, Arg-506, and Arg-679.
J Biol Chem
; 279(8): 6567-75, 2004 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-14660667